Evidence map›Paper›PMID 39819639›Full record

SynthesisParasitology2024

Ivermectin

Cesar Henriquez-Camacho, Jose A Pérez-Molina, Dora Buonfrate, Paola Rodari, Eduardo Gotuzzo, Benilde Luengo, María Nieves Plana

Abstract readSystematic ReviewComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Parasitology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cesar Henriquez-CamachoFaculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.ORCID 0000-0002-6714-5840
Jose A Pérez-MolinaNational Reference Centre for Imported Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Dora BuonfrateDepartment of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.ORCID 0000-0003-0108-6822
Paola RodariDepartment of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Eduardo GotuzzoFaculty of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Benilde LuengoResearch Unit, Universidad Francisco de Vitoria (UFV), Madrid, Spain.
María Nieves PlanaHealth Technology Assessment Unit, Hospital Universitario Ramón y Cajal and Universidad de Alcalá (IRYCIS), CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim was to assess the efficacy of ivermectin

Indexed as

AnthelminticsIvermectinMacrolidesStrongyloides stercoralisStrongyloidiasisAdultAnimalsFemaleHumansMaleMiddle AgedTreatment OutcomeAnthelminticsIvermectinMacrolidesmoxidectinivermectinmoxidectinparasitological cureStrongyloides stercoralis

Identifiers

PMID39819639
PMCPMC12052429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.